- Risks
- Generative AI chatbots and AI-native legal and research tools, like Anthropic's Claude legal plug-in, could reduce demand for RELX's subscription research products over time. Legal is the segment investors worry about most, and it already carrieshas RELX's lowest operating margin, at 21.7% in the first half of 2026.
RELX's Risk segment sells data to government agencies, including ICE for immigration enforcement. In March 2026, more than 200 journalists at Law360 and related titles publicly objected to this, andThe American Friends Service Committee estimates that RELX subsidiaries have received more than $172 million in US Department of Homeland Security contracts sincefrom 2005 to 2024. Continued controversy could bring reputational and regulatory risk.
Net debt rose to £8,733m (2.3x EBITDA) at the end of June 2026, up from £7,201m (2.0x) at the end of 2025, asbecause RELX fundedspent £1,750m ofon buybacks plus. In the second half, more buybacks, the interim dividend and the Doctrine acquisition add to net debt. Further leverage increases would use up capacity for future deals or buybacks.
LexisNexis Risk Solutions has suffered multiple data breaches, includinghad more than one confirmed indata breach. In March 2026 affecting roughly, LexisNexis confirmed a breach; the attacker claimed about 400,000 records, and the company said that the data was mostly from before 2020 and held no Social Security or financial data. In 2025, LexisNexis Risk Solutions disclosed a different breach that affected about 364,000 people. Repeated breaches could damage trust with customers who rely on RELX to protect sensitive personal data.
The Doctrine acquisition and other legal-AI deals expand RELX's position in European legal information services, where regulators may scrutinize further consolidation given RELX's already strong market position.
RELX's Exhibitions segment, about 12% of revenue, depends on global business travel and event spending, which can fall quickly in a recession or health scare, as it did during the pandemic.
Because much of the current share-price discount is tied to a single debate over whether AI helps or hurts RELX, a new competing AI product launch, even one aimed at a rival, can trigger another sharp, sentiment-driven drop in RELX's stock regardless of its own results, as happened in February 2026.
- Balance sheet
- Cash: £220M
Debt: £8.9B
Net debt: £8.7B
Net debt / EBITDA: 2.3× (medium)
Interest cover: 1213×
Ratings: S&P A- (stable outlook), Fitch A- (stable outlook), Moody's A3 (stable outlook)
RELX funds itself with strong subscription cash flow and with bonds, bank loans and commercial paper, mostly in US dollars and euros. The borrowings have an average remaining life of only 3.7 years and, down from 4.0 years at the end of 2025. Only 54% are at fixed rates, sodown from 66%. So RELX refinances often and higher rates pass through to its interest cost. Its finance subsidiaries issue the debt, and RELX PLC guarantees it. At June 30, 2026, net debt was £8,733m, up £1,532m in six months, because RELX spent £1,750m on buybacks. Debt includes £119m of leases. The leverage ratio uses net debt including pensions and EBITDA for the twelve months to June 30, 2026, calculated in US dollars, and it was up from 2.0 times at the end of 2025. Interest cover is first-half adjusted operating profit of £1,727m over adjusted net interest of £138m. In June 2026, RELX issued two €750m bonds, one at 3.25% for 3 years and one at 3.75% for 8 years. About $4.1bn of committed bank facilities, mostly to November 2030, were undrawn. The pension schemes showed a small surplus of £87m. Shareholders' equity was only £1,238m, because years of buybacks returned more cash than the book value of the company. This is not a problem while cash flow covers the debt easily. RELX pays out about half of adjusted earnings as dividends. It uses most of the remaining free cash flow, and some new debt, for buybacks. Leverage near 2.3 times leaves room for buybacks and small acquisitions. But a large debt-funded deal would need a pause in buybacks.
As of 2026-06-30.
- Recent events
- 2026-09-0307: RELX started a new £125m share buyback tranche, to run until October 21, 2026. With the earlier tranches, the 2026 buybacks reach about £2,125m of the £2,250m target. This total is our sum of RELX's own announcements.
2026-09-04: RELX announced that it had completed its acquisition of Doctrine, a French legal AI platform used daily by 27,000 legal professionals across France, Italy, Germany, Spain, and Luxembourg, extending. The deal extends Lexis+ AI into continental Europe. RELX did not disclose the price.
2026-07-23: RELX reported H1 2026 results: revenue of £4,871m, up 7% on an underlying basis, and adjusted operating profit of £1,727m, up 9%. All four segments grew, led by Legal at +10% revenue and +13% profit. The interim dividend rose 7% to 20.9p, and £1,750m of shares were repurchased in the half.
2026-04-28: RELX agreed to acquire Doctrine, a French legal AI platform, to expand LexisNexis's legal AI offering across continental Europe, including France, Italy, Germany, and Spain.
2026-04-23: In an AGM trading update, RELX said it had started 2026 well across all four business areas and reaffirmed full-year guidance for strong underlying growth in revenue, profit, and earnings per share.
2026-03-05: The analysts downgraded competitors Wolters Kluwer and Thomson Reuters to Narrow moat ratings on AI disruption risk, while keeping RELX at Wide, and raised RELX's Uncertainty Rating to Medium from Low.
2026-02-12: RELX reported full-year 2025 results: revenue of £9,590m, up 7% on an underlying basis, and adjusted operating profit of £3,342m, up 9%. Adjusted earnings per share grew 10% to 128.5p. The board raised the full-year dividend 7% to 67.5p and set a £2,250m share buyback target for 2026.
2026-02-03: RELX shares fell about 14% in a single day after Anthropic launched a Claude legal plug-in aimed at in-house legal teams, part of a broader selloff in legal and data-analytics stocks, including Thomson Reuters and Wolters Kluwer, on fears of AI disruption to subscription research businesses.